Literature DB >> 12645087

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

Javier Sáez-Valero1, Mercedes Costell, Magnus Sjögren, Niels Andreasen, Kaj Blennow, Juan M Luque.   

Abstract

Reelin is an essential glycoprotein for correct cytoarchitectonic organization during CNS development. Its function in the adult brain is far less well understood, but altered brain and blood reelin levels have been reported in some psychiatric disorders, and the possibility has been considered of an involvement of the reelin signaling pathway in neurodegeneration. Here we report, for the first time, the presence of detectable levels of reelin in rat and human cerebrospinal fluid (CSF) and show evidence for the involvement of a 180-kDa reelin fragment in two neurodegenerative disorders. This fragment was analyzed by Western blotting in CSF samples from 13 healthy control individuals and 14 frontotemporal dementia (FTD) and 20 Alzheimer's disease (AD) patients. Increased CSF 180-kDa reelin was found in FTD (161.7 +/- 6.7 arbitrary units; a.u.) and AD (151.4 +/- 3.8 a.u.) compared with control individuals (141.4 +/- 1.2 a.u., P < 0.05). Our results strongly suggest the involvement of reelin signaling in neurodegenerative pathologies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645087     DOI: 10.1002/jnr.10554

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  21 in total

1.  Cleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein.

Authors:  Mari Koie; Kyoko Okumura; Arisa Hisanaga; Takana Kamei; Kazutomo Sasaki; Mengyan Deng; Atsushi Baba; Takao Kohno; Mitsuharu Hattori
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

2.  Reelin-mediated Signaling during Normal and Pathological Forms of Aging.

Authors:  Jana Doehner; Irene Knuesel
Journal:  Aging Dis       Date:  2010-06-04       Impact factor: 6.745

3.  Reelin expression and glycosylation patterns are altered in Alzheimer's disease.

Authors:  Arancha Botella-López; Ferran Burgaya; Rosalina Gavín; M Salud García-Ayllón; Estrella Gómez-Tortosa; Jordi Peña-Casanova; Jesús M Ureña; José A Del Río; Rafael Blesa; Eduardo Soriano; Javier Sáez-Valero
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies.

Authors:  Agata Mata; Laura Urrea; Silvia Vilches; Franc Llorens; Katrin Thüne; Juan-Carlos Espinosa; Olivier Andréoletti; Alejandro M Sevillano; Juan María Torres; Jesús Rodríguez Requena; Inga Zerr; Isidro Ferrer; Rosalina Gavín; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2016-10-10       Impact factor: 5.590

5.  Ataxia telangiectasia alters the ApoB and reelin pathway.

Authors:  Júlia Canet-Pons; Ralf Schubert; Ruth Pia Duecker; Roland Schrewe; Sandra Wölke; Matthias Kieslich; Martina Schnölzer; Andreas Chiocchetti; Georg Auburger; Stefan Zielen; Uwe Warnken
Journal:  Neurogenetics       Date:  2018-10-21       Impact factor: 2.660

Review 6.  The Role of Reelin Signaling in Alzheimer's Disease.

Authors:  Nan-Nan Yu; Meng-Shan Tan; Jin-Tai Yu; An-Mu Xie; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-10-21       Impact factor: 5.590

7.  The Key Factors Predicting Dementia in Individuals With Alzheimer's Disease-Type Pathology.

Authors:  Andrew N McCorkindale; Ellis Patrick; James A Duce; Boris Guennewig; Greg T Sutherland
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

8.  Beta-amyloid impairs reelin signaling.

Authors:  Inmaculada Cuchillo-Ibáñez; Valeria Balmaceda; Arancha Botella-López; Alberto Rabano; Jesus Avila; Javier Sáez-Valero
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 9.  Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.

Authors:  Sarah Jesse; Petra Steinacker; Stefan Lehnert; Frank Gillardon; Bastian Hengerer; Markus Otto
Journal:  CNS Neurosci Ther       Date:  2009-03-09       Impact factor: 5.243

10.  Increased Blood-Reelin-Levels in First Episode Schizophrenia.

Authors:  Tobias Hornig; Carola Haas; Lukas Sturm; Bernd Fiebich; Ludger Tebartz van Elst
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.